Research and Development

Showing 15 posts of 9603 posts found.

New biotech facility to bring 350 jobs to Dublin

February 14, 2018 Manufacturing and Production, Research and Development Dublin, Ireland, MSD, pharma

MSD has announced plans to invest in a new biotechnology facility in Dublin which it claims will create 350 jobs …

Lilly posts promising P3 Taltz data

February 14, 2018 Research and Development Cosentyx, Eli Lilly, IL-17, Novartis, Taltz, biotech, drugs, pharma, pharmaceutical

The IL-17 market is a crowded space, and one dominated by Novartis’ Cosentyx. Eli Lilly is attempting to challenge that, …
merckincweb

MSD shuts down Phase 3 trial in prodromal Alzheimer’s

February 14, 2018 Research and Development Alzheimer's, MSD, pharma, verubecestat

Another blow has been dealt to the field of Alzheimer’s research as MSD announces yet another trial failure of a …
finland_flag

Pfizer taps real world evidence for CVD in new partnership

February 14, 2018 Research and Development BC Platforms, Pfizer, biotech, cardiovascular disease, drugs, pharma, pharmaceutical

BC Platforms, a company that focuses on genomic data managements and analysis, has announced that it has partnered with Pfizer …

Bill & Melinda Gates Foundation shows faith in CureVac

February 14, 2018 Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, influenza, pharma, pharmaceutical

The Bill & Melina Gates Foundation had already invested $52 million in CureVac, back in 2015, and has now doubled …
jason_drees_arizona_state_university

Cancer-targeting nanorobots successfully starve and shrink tumours, study shows

February 13, 2018 Manufacturing and Production, Research and Development Arizona State university, Cancer, Chinese Academy of Sciences, National Center for Nanoscience and Technology, nanorobots, pharma

A team of researchers from Arizona State University (ASU), in partnership with the Chinese Academy of Sciences’ National Center for …
flu

New flu med can destroy influenza virus in one day

February 13, 2018 Manufacturing and Production, Research and Development Roche, Shionongi, Tamiflu, biotech, drugs, flu, influenza, pharma, pharmaceutical

Researchers in Japan have achieved a notable success in a Phase 3 clinical trial to determine whether a new vaccine …
network-1989146_960_720

Taking a look behind the scenes of Serialisation

February 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Serialization, biotech, drugs, pharma, pharmaceutical, serialisation

The reaction from the pharmaceutical industry has been mixed since the announcement of serialisation requirements. Ben Hargreaves discovers the challenges …
bi_microparts_image

Boehringer terminates Alzheimer’s candidate after Phase 2 failure

February 12, 2018 Research and Development, Sales and Marketing Alzheimer's, Boehringer Ingelheim, dementia, pharma

Boehringer Ingelheim has announced its intention to halt development of its candidate BI 409306 in the treatment of Alzheimer’s after …
david_kendall

MannKind entices Lilly VP to CMO role

February 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical

MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be …
fuji

Fujifilm partners with Takeda, stepping into regenerative medicine

February 9, 2018 Medical Communications, Research and Development Fujifilm, Takeda, biotech, drugs, pharma, pharmaceutical

Fujifilm has been steadily building up its regenerative medicines, with several acquisitions of companies that hold expertise in the area …
peter_goldschmidt_web

Stada poaches Novartis exec for fifth CEO in two years

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Stada, appointment

Stada has revealed its new CEO as Peter Goldschmidt, the current head of North American operations at Novartis’ generics and …
bob_hugin1

Celgene Executive Chairman Bob Hugin retires

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Fresh from its acquisition of Juno Therapeutics, Celgene announced that its Executive Chairman Bob Hugin was to retire effective 5 …
online_feature_image

New Year, new goals

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer Research UK, Chiesi, EMA, FDA, Genetic Alliance, pharma

With the New Year begun in earnest, Pharmafocus speaks to a range of players in pharma and the life sciences …
The Gateway to Local Adoption Series

Latest content